These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26432712)

  • 1. [Update peripheral arterial occlusive disease].
    Blessing E
    Herz; 2015 Nov; 40(7):1013-22; quiz 1023-4. PubMed ID: 26432712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular intervention for tibial artery occlusive disease in patients with critical limb ischemia.
    Huang ZS; Schneider DB
    Semin Vasc Surg; 2014 Mar; 27(1):38-58. PubMed ID: 25812758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Percutaneous access for endovascular therapy of PAOD. Femoral, popliteal and pedal].
    Kamper L; Haage P
    Radiologe; 2016 Mar; 56(3):223-32. PubMed ID: 26801186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
    Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
    Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wound Healing Outcomes and Health-Related Quality-of-Life Changes in the ACHILLES Trial: 1-Year Results From a Prospective Randomized Controlled Trial of Infrapopliteal Balloon Angioplasty Versus Sirolimus-Eluting Stenting in Patients With Ischemic Peripheral Arterial Disease.
    Katsanos K; Spiliopoulos S; Diamantopoulos A; Siablis D; Karnabatidis D; Scheinert D
    JACC Cardiovasc Interv; 2016 Feb; 9(3):259-267. PubMed ID: 26777329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
    J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous vascular interventions in the superficial femoral artery. A review.
    Wiesinger B; Heller S; Schmehl J; Claussen CD; Wiskirchen J; Tepe G
    Minerva Cardioangiol; 2006 Feb; 54(1):83-93. PubMed ID: 16467744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.
    ; Conte MS; Pomposelli FB; Clair DG; Geraghty PJ; McKinsey JF; Mills JL; Moneta GL; Murad MH; Powell RJ; Reed AB; Schanzer A; Sidawy AN;
    J Vasc Surg; 2015 Mar; 61(3 Suppl):2S-41S. PubMed ID: 25638515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in patterns of peripheral arterial occlusive disease and eligibility for endovascular treatment.
    Zimmermann A; Arzt F; Wildgruber M; Schuster T; Wendorff H; Eckstein HH
    Vasa; 2012 Nov; 41(6):432-9. PubMed ID: 23129039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evidence to support the use of focal force balloon technology to improve outcomes in the treatment of lower extremity arterial occlusive disease.
    Blessing E; Lugenbiel I; Holden A
    J Cardiovasc Surg (Torino); 2019 Feb; 60(1):14-20. PubMed ID: 30350932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug eluting balloons.
    Diehm NA; Hoppe H; Do DD
    Tech Vasc Interv Radiol; 2010 Mar; 13(1):59-63. PubMed ID: 20123434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral drug-eluting technology.
    Franzone A; Stabile E; Trimarco B; Esposito G
    Cardiol Clin; 2015 Feb; 33(1):151-62. PubMed ID: 25439337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
    Canaud L; Alric P; Berthet JP; Marty-Ané C; Mercier G; Branchereau P
    J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular interventions in iliac and infrainguinal occlusive artery disease.
    Ruef J; Hofmann M; Haase J
    J Interv Cardiol; 2004 Dec; 17(6):427-35. PubMed ID: 15546296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the use of drug eluting stents in below-the-knee lesions.
    Trombert D; Caradu C; Brizzi V; Bérard X; Midy D; Ducasse E
    J Cardiovasc Surg (Torino); 2015 Feb; 56(1):67-71. PubMed ID: 25428562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary management of infrapopliteal peripheral arterial disease.
    Falluji N; Mukherjee D
    Angiology; 2011 Aug; 62(6):490-9. PubMed ID: 21421622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.